Is Enxi Diping covered by domestic medical insurance?

Ensidipine (enasidenib) is an antineoplastic agent indicated for the treatment of patients with relapsed or refractory acute myeloid leukemia (AML) with IDH2 mutations detected in an FDA-approved test. Encidipine was approved by the Nikkei FDA in 2017, but it has not yet been marketed in China, so it has not been included in medical insurance.

Currently, ensidipine is available in both original and generic versions. The original version is available in the United States. The price in pharmacies is about 100mg for 30 tablets300,000 yuan. Regularly marketed generic drugs include the Bangladeshi version, the retail price of Ziska Pharmaceuticals in Bangladesh50mg60tablets4thousand, the retail price of Everest Pharmaceuticals in Bangladesh50mg30< span>tablets5about one thousand yuan,The retail price of Lucius Pharmaceuticals in Laos50mg30pills2about one thousand yuan. Patients can choose drug versions based on their financial situation.

The recommended dose of ensidipine is 100 mg orally once daily with or without food until disease progression or unacceptable toxicity occurs. For patients without disease progression or unacceptable toxicity, treat for at least 6 months to allow time for clinical response. Do not split or crushensidipinetablets. Take ensidipinetablets by mouth at about the same time each day. If a dose of ensidipine is vomited, missed, or not taken at the usual time, take the dose as soon as possible that day and resume the normal time the next day. The most common adverse reactions of ensidipine(≥20%) are nausea, vomiting, diarrhea, increased bilirubin and decreased appetite. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.